Envoy Medical (COCH) Net Income towards Common Stockholders (2021 - 2026)
Envoy Medical (COCH) posted Net Income towards Common Stockholders of -$5.7 million for Q1 2026, up 26.32% sequentially from -$7.7 million in Q4 2025, and up 8.58% YoY from -$5.3 million in Q1 2025.
Envoy Medical (COCH) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Envoy Medical has reported Net Income towards Common Stockholders for 6 years, with the latest figure at -$5.7 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 8.58% year-over-year to -$5.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$28.1 million (down 5.84% YoY) and the FY2025 annual result came in at -$28.7 million, down 2.46% from the prior year.
- Net Income towards Common Stockholders grew to -$5.7 million in Q1 2026 per COCH's latest filing, from -$7.7 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $18.0 million in Q2 2022 and troughed at -$13.3 million in Q1 2023.
- A 5-year average of -$4.3 million and a median of -$6.3 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2022 and 2024: Net Income towards Common Stockholders jumped 24184.87% in 2022, then plunged 639.71% in 2024.
- Over 5 years, Net Income towards Common Stockholders stood at -$11.5 million in 2022, then surged by 45.11% to -$6.3 million in 2023, then fell by 22.0% to -$7.7 million in 2024, then declined by 0.66% to -$7.7 million in 2025, then advanced by 26.32% to -$5.7 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$5.7 million, -$7.7 million, and -$7.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Envoy Medical | 77.89 Mn | 58.22 Mn | -227,000.00 | -7.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.27 Mn |
| Mar 31, 2026 | -5.70 Mn |
| Dec 31, 2025 | -7.74 Mn |
| Sep 30, 2025 | -7.75 Mn |
| Jun 30, 2025 | -6.94 Mn |
| Mar 31, 2025 | -6.24 Mn |
| Dec 31, 2024 | -7.69 Mn |
| Sep 30, 2024 | -7.34 Mn |
| Jun 30, 2024 | -5.31 Mn |
| Mar 31, 2024 | -7.60 Mn |
| Dec 31, 2023 | -6.30 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | -809,615.00 |
| Mar 31, 2023 | -13.25 Mn |
| Dec 31, 2022 | -11.48 Mn |
| Sep 30, 2022 | -1.34 Mn |
| Jun 30, 2022 | 18.03 Mn |
| Mar 31, 2022 | 2.49 Mn |
| Dec 31, 2021 | -3.43 Mn |
| Sep 30, 2021 | 4.45 Mn |